The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *
Open accessAbstract
Although the natural history of autoimmune hepatitis (AIH) has been characterized, little is known about patients who present asymptomatically. Consequently, whether they require immunosuppressive therapy with its associated complications is unclear. To compare the natural history of asymptomatic AIH with symptomatic AIH, a large cohort of patients from a single center was examined. All patients with a clinical diagnosis of AIH were reassessed using the revised criteria of the International Autoimmune Hepatitis Group. Liver histology, response to therapy, and survival were assessed. Patients asymptomatic at presentation (n = 31) had lower serum aminotransferase, bilirubin, and immunoglobulin G (IgG) values at baseline. Half of the asymptomatic patients received no therapy, and their survival was no different from that of the total cohort. Ten-year survival was 80.0% (62.5%-97.5%) in the asymptomatic group and 83.8% (75.1%-92.6%) in the symptomatic patients ( P = NS). Survival to liver-related endpoints at 10 years was similar in both groups: 89.5% (75.7%-100%) asymptomatic and 83.8% (75.1%-92.6%) symptomatic patients ( P = NS). Patients with cirrhosis at baseline had poorer 10-year survival (61.9% [CI 44.9%-78.9%]) than those without cirrhosis at presentation (94.0% [CI 87.4%-100%]) ( P = .003) regardless of whether they presented with symptoms or whether they received immunosuppressive therapy. In conclusion , patients with AIH who are asymptomatic at presentation have a good prognosis and may not require immunosuppressive therapy. Cirrhosis on initial liver biopsy portends a poor prognosis in all patients with AIH. (Hepatology 2005.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationNatural history of chronic hepatitis C
Seeff, L. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36806 · Cited by 1,424
Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., & Schoenfield, L. J. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33223-8 · Cited by 779
Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis
COOK, G. C., MULLIGAN, R., & SHERLOCK, S. (1971) · QJM · doi:10.1093/oxfordjournals.qjmed.a067264 · Cited by 564
CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
Murray-Lyon, I., Stern, R. B., & Williams, R. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92125-9 · Cited by 468
Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331502 · Cited by 382
Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
Roberts, S., Therneau, T., & Czaja, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608895 · Cited by 299
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J.-F., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 290
Read, A. E., Sherlock, S., & Harrison, C. V. (1963) · Gut · doi:10.1136/gut.4.4.378 · Cited by 212
Verma, S., Gunuwan, B., Mendler, M., Govindrajan, S., & Redeker, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30457.x · Cited by 196
The nature and prognostic implications of autoimmune hepatitis with an acute presentation
Nikias, G. A., Batts, K. P., & Czaja, A. J. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80251-3 · Cited by 182
Mistilis, S. P., & Blackburn, C. R. B. (1970) · The American Journal of Medicine · doi:10.1016/0002-9343(70)90049-5 · Cited by 167
Natural History, Clinical Features, and Treatment of Autoimmune Hepatitis
Czaja, A. (1984) · Seminars in Liver Disease · doi:10.1055/s-2008-1040641 · Cited by 159
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. L. (1988) · Hepatology · doi:10.1002/hep.1840080414 · Cited by 134
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis
Kogan, J., Safadi, R., Ashur, Y., Shouval, D., & Ilan, Y. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200207000-00016 · Cited by 130
Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis†
Czaja, A. J., & Carpenter, H. A. (2004) · Hepatology · doi:10.1002/hep.20235 · Cited by 128
Long-term follow-up of chronic active hepatitis of moderate severity.
de Groote, J., Fevery, J., & Lepoutre, L. (1978) · Gut · doi:10.1136/gut.19.6.510 · Cited by 124
Czaja, A. J., Rakela, J. L., & Ludwig, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90503-3 · Cited by 120
Chronic liver disease in young people
Willocx, R. G., & Isselbacher, K. J. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90090-0 · Cited by 96
Severe chronic active liver disease
Schalm, S. W., Korman, M. G., Summerskill, W. H. J., Czaja, A. J., & Baggenstoss, A. H. (1977) · Digestive Diseases and Sciences · doi:10.1007/bf01076196 · Cited by 91
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis
Czaja, A. J., Muratori, P., Muratori, L., Carpenter, H. A., & Bianchi, F. B. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0924.x · Cited by 89
Classification and Treatment of Chronic Active Liver Disease
Schoenfield, L. J., Summerskill, W. H. J., & Geall, M. G. (1968) · Gastroenterology · doi:10.1016/s0016-5085(19)33990-3 · Cited by 89
Davis, G. L., Czaja, A. J., & Ludwig, J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90186-0 · Cited by 84
Wang, K. K., & Czaja, A. J. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91701-0 · Cited by 29
Cited by
Simplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759
Metadata
- Authors
- Feld, J. J., Dinh, H., Arenovich, T., Marcus, V. A., Wanless, I. R., & Heathcote, J. E.
- Venue
- Hepatology
- Published
- 2005-07
- Volume
- 42
- Issue
- 1
- Pages
- 53-62
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1997647425
- Cited by
- 367
- References
- 24
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.